Polyrizon completes all five U.S. site contracts for NASARIX allergy study
Polyrizon (PLRZ) has completed all five U.S. site contracts for its NASARIX first-in-human allergy study.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.